Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Zuyén González"'
Autor:
Xitlally Popa, Beatriz García, Karla P. Fuentes, Vivian Huerta, Karen Alvarez, Carmen E. Viada, Elia Neninger, Pedro C. Rodríguez, Zuyen González, Amnely González, Tania Crombet, Zaima Mazorra
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
We previously reported that CIMAvax-EGF vaccine is safe, immunogenic and efficacious to treat advanced non-small-cell lung cancer (NSCLC) patients. A phase III trial was designed using an optimized immunization schedule. It included higher antigen do
Externí odkaz:
https://doaj.org/article/e59a8c57e455495bbcf63ebd16c0a490
Autor:
Zaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, Anet Valdés, Raghvendra M. Srivastava, Tatiana M. García-Bates, Esperanza Hechavarría, Zuyen González, Amnely González, Martha Lugiollo, Iván Cuevas, Carlos Frómeta, Braulio F. Mestre, Maria C. Barroso, Tania Crombet, Robert L. Ferris
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Survival benefit and long-term duration of clinical response have been seen using the epidermal growth factor receptor (EGFR)-targeted monoclonal antibody (mAb) nimotuzumab. Blocking EGFR signaling may not be the only mechanism of action underlying i
Externí odkaz:
https://doaj.org/article/c51e8c0dc64d405b837c571b012a0803
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 284KB, CONSORT study diagram.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60661ba2a8843d50bd85fdb4eb676e6d
https://doi.org/10.1158/1078-0432.22446792
https://doi.org/10.1158/1078-0432.22446792
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 61KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1deb9012efb687f159146fcfb489b73d
https://doi.org/10.1158/1078-0432.22446786.v1
https://doi.org/10.1158/1078-0432.22446786.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 2804KB, Association of antibody response with patient's survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd09b753c0d34f30da445a1a0dbe7c7
https://doi.org/10.1158/1078-0432.22446771
https://doi.org/10.1158/1078-0432.22446771
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
Purpose: Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of efficacy and safety of racotumomab as switch maintenance for patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a606512ef5ea47aa6c0cf297ef32478
https://doi.org/10.1158/1078-0432.c.6520869.v1
https://doi.org/10.1158/1078-0432.c.6520869.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 47KB, Adverse event severity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df1d99a5fb93b113837a98c7006a8a25
https://doi.org/10.1158/1078-0432.22446783.v1
https://doi.org/10.1158/1078-0432.22446783.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 132KB, Number of doses received, maximal titer and isotype analysis against Racotumomab-mAb and NeuGcGM3, percentages of binding and cytotoxicity against L1210 cells, and survival times in vaccinated NSCLC patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02cb2fc69f59299e4d9f59c6f8eeaee4
https://doi.org/10.1158/1078-0432.22446777.v1
https://doi.org/10.1158/1078-0432.22446777.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 66KB, Summary of adverse events.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ac1e7dd3de32d9c423d22f39332f15
https://doi.org/10.1158/1078-0432.22446780
https://doi.org/10.1158/1078-0432.22446780
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 137KB, Association of functional capacity of elicited anti-NeuGcGM3 antibodies with patient's survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dda254ca2410c9cf708ad664ad92125
https://doi.org/10.1158/1078-0432.22446768.v1
https://doi.org/10.1158/1078-0432.22446768.v1